From clinical20b@alcorn.edu Sun Dec 20 10:41:54 1998
Return-Path: <clinical20b@alcorn.edu>
Delivered-To: bguenter@hal.qcc.sk.ca
Received: (qmail 25178 invoked by alias); 20 Dec 1998 10:41:53 -0000
Delivered-To: bruce.guenter@qcc.sk.ca
Received: (qmail 25173 invoked from network); 20 Dec 1998 10:41:52 -0000
Received: from unknown (HELO jewel.crown.edu) (12.2.50.98)
  by hal.qcc.sk.ca with SMTP; 20 Dec 1998 10:41:52 -0000
Received: from alcorn.edu (205-143-78.ipt.aol.com [152.205.143.78]) by jewel.crown.edu (8.8.8/8.6.9) with SMTP id EAA05753; Sun, 20 Dec 1998 04:24:31 -0600 (CST)
Date: Sun, 20 Dec 1998 04:24:31 -0600 (CST)
From: clinical20b@alcorn.edu
Message-Id: <199812201024.EAA05753@jewel.crown.edu>
To: clinical20b@alcorn.edu
Subject: NBCReport:1st Aphrodisiac Drug Appr

The announcement of this scientific breakthrough,
has set off a media fire-storm.  In the last few days,
the remarkable qualities of Androstenone Pheromones
have been featured in every major publication,
newspaper, national magazine, and television magazine.
>From 20/20, Hard Copy, and Dateline NBC, to the N.Y.
Times, and the American Journal of Modern Medicine.

Several independent research institutes have concluded
studies on the benefits of Androstenone (You may have
heard about the most recent study on CNN.)

TO READ MORE ABOUT THIS REVOLUTIONARY
MEDICAL DISCOVERY and the CNN REPORT
go to our new sites at :



http://ap10ml.webjump.com/index.htm



****
OR
****



http://www.angelfire.com/on/ap10ml/





